CasNo.188627-80-7,Eptifibatide,(188627-80-7) Suppliers

10 Milligram	Negotiable

Min.Order :10 Milligram
Purity: 99%
Payment Terms : L/C,D/A,D/P,T/T

Keywords

Eptifibatide Eptifibatide Acetate 188627-80-7

Quick Details

Appearance:white powder
Application:Eptifibatide
PackAge:Vial or customized
ProductionCapacity:100|Kilogram|Month
Storage:2-8℃ sealed and away from light
Transportation:Ocean and air shipping

Superiority:

GMP Manafacturer

High Purity

Competitive Price

Short Delivery Time

One of the remarkable features of our Eptifibatide is its rapid onset of action. It quickly reaches therapeutic levels in the bloodstream, exerting its anti - platelet effects almost immediately. This rapid response is crucial in emergency situations where time is of the essence. Moreover, its action is reversible. Once the treatment is discontinued, platelet function gradually returns to normal, minimizing the risk of excessive bleeding. This unique characteristic allows for precise control of the anti - platelet therapy, enhancing patient safety.

Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.

Details:

Eptifibatide CAS No.: 188627-80-7

Peptide Sequence:
Mpa-Har-Gly-Asp-Trp-Pro-Cys-NH₂(Disulfide bridge: Mpa1-Cys6)

Eptifibatide is a platelet glycoprotein IIb/IIIa receptor reversible antagonist. It is used For acute coronary syndrome, coronary intervention before treatment and acute Q-wave myocardial infarction. It can relieve unstable angina symptoms and reduce the incidence of cardiovascular events.

Product Name	Eptifibatide
CAS NO.	188627-80-7
Appearance	White Powder
Purity	99% or customized
Application	Drug peptides
Usage	Eptifibatide is a platelet glycoprotein IIb/IIIa receptor reversible antagonist.

Company Profile

Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.